Home/Filings/4/0001209191-16-108174
4//SEC Filing

AQUINOX PHARMACEUTICALS, INC 4

Accession 0001209191-16-108174

$NGNECIK 0001404644operating

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:34 PM ET

Size

6.0 KB

Accession

0001209191-16-108174

Insider Transaction Report

Form 4
Period: 2016-03-10
Alam Kamran
CFO, Vice President Finance
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-03-10+40,00040,000 total
    Exercise: $8.08Exp: 2026-03-09Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable at a rate of twenty-five percent of the total number of shares underlying the options on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares underlying the options each monthly anniversary of the vesting commencement date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total number of shares underlying the options shall be fully vested on the four-year anniversary of the vesting commencement date.

Issuer

AQUINOX PHARMACEUTICALS, INC

CIK 0001404644

Entity typeoperating

Related Parties

1
  • filerCIK 0001404644

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:34 PM ET
Size
6.0 KB